An innate sense of danger

Seminars in Immunology

Volumn 10, Issue 5, 1998, Pages 399-415

  Matzinger, Polly ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNITY; GRAFT REJECTION; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; REVIEW; TRANSPLANTATION; TUMOR IMMUNITY;

EID: 0032191916     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1006/smim.1998.0143     Document Type: Article

References (86)

1. 1. Matzinger P (1994) Tolerance, danger and the extended family. Annu Rev Immunol 12:991-1045
2. 2. Janeway CA Jr (1989) Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 54:11-13
3. 3. Janeway CA Jr (1992) The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today 13:11-16
4. 4. Fearon DT, Locksley RM (1996) The instructive role of innate immunity in the acquired immune response. Science 272:50-53
5. 5. Bretscher P, Cohn M (1970) A theory of self-nonself discrimination. Science 169:1042-1049
6. 6. Lafferty KJ, Cunningham A (1975) A new analysis of allogenic interactions. Aust J Exp Biol Med Sci 53:27-42
7. 7. Cohn M, Langman RE (1990) The protecton: the unit of humoral immunity selected by evolution. Immunol Rev 115:11-147
8. 8. Jenkins MK, Schwartz RH (1987) Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J Exp Med 165:302-319
9. 9. Janeway CA Jr, Goodnow CC, Medzhitov R (1996) Danger - pathogen on the premises Immunological tolerance. Curr Biol 6:519-522
10. 10. Fuchs E (1993) Reply from Ephraim Fuchs. Immunol Today 14:236-237
11. 11. Matzinger P, Fuchs EJ (1996) Beyond 'self' and 'non-self': immunity is a conversation not a war. J NIH Res 8:35-39
12. 12. Steinman RM (1997) The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991 9:271-296
13. 13. Fearon DT (1997) Seeking wisdom in innate immunity (news; comment). Nature 388:323-324
14. 14. Ling N, Burgus R, Guillemin R (1976) Isolation, primary structure and synthesis of alpha-endorphin and gamma-endorphin, two peptides of hypothalamic-hypophysial origin with morphinomimetic activity. Proc Natl Acad Sci USA 73:3042-3046
15. 15. Pugin J, Heumann ID, Tomasz A, Kravchenko VV, Akamatsu Y, Nishijima M, Glauser MP, Tobias PS, Ulevitch RJ (1994) CD14 is a pattern recognition receptor. Immunity 1:509-516
16. 16. Devitt A, Moffatt OD, Raykundalia C, Capra JD, Simmons DL, Gregory CD (1998) Human CD14 mediates recognition and phagocytosis of apoptotic cells (see comments). Nature 392:505-509
17. 17. Haziot A, Ferrero E, Kontgen F, Hijiya N, Yamamoto S, Silver J, Stewart CL, Goyert SM (1996) Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 4:407-414
18. 18. Sallusto F, Cella M, Danieli C, Lanzavecchia A (1995) Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products (see comments). J Exp Med 182:389-400
19. 19. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson J (1989), in Molecular Biology of the Cell pp 405-415. 2nd ed Gariand Publishing, New York
20. 20. Yi AK, Tuetken R, Redford T, Waldschmidt M, Kirsch J, Krieg AM (1998) CpG motifs in bacterial DNA activate leukocytes through the pH-dependent generation of reactive oxygen species. J Immunol 160:4755-4761.
21. 21. Srivastava PK, Menoret A, Basu S, Binder RJ, McQuade KL (1998) Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world. Immunity 8:657-665
22. 22. Arnheiter H, Frese M, Kambadur R, Meier E, Hailer O (1996) Mx transgenic mice-animal models of health. Curr Top Microbiol Immunol 206:119-147
23. 23. Ghosh S, May MJ, Kopp EB (1998) NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16:225-260
24. 24. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr (1997) A human homologue of the Drosophila Toll protein signals activation of adaptive immunity (see comments). Nature 388:394-397
25. 25. Albert ML, Sauter B, Bhardwaj N (1998) Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392:86-89
26. 26. Kurts C, Kosaka H, Carbone FR, Miller JF, Heath WR (1997) Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J Exp Med 186:239-245
27. 27. Wilbanks GA, Streilein JW (1997) Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor - beta. Eur J Immunol Apr 1992:22:1031-1036
28. + T cells to secrete IL-4. Adv Exp Med Biol 417:375-381
29. 29. Stavnezer J, Abbott J, Sirlin S (1997) Immunoglobulin heavy chain switching in cultured I.29 murine B lymphoma cells: commitment to an IgA or IgE switch. Curr Top Microbiol Immunol 1984:113:109-116
30. + T cells: IL-4 and IFN-gamma have opposing effects, while TGF-beta positively regulates its own production. J Immunol 160:5719-5728
31. 31. Donohoe JA, Andrus L, Bowen KM, Simeonovic C, Prowse SJ, Lafferty KJ (1983) Cultured thyroid allografts induce a state of partial tolerance in adult recipient mice. Transplantation 35:62-67
32. 32. Bowen KM, Prowse SJ, Lafferty KJ (1981) Reversal diabetes by islet transplantation: vulnerability of the established allograft. Science 213:1261-1262
33. 33. Davies H, Kamada N, Roser B (1984) Transplantation Immunology clinical and experimental, in Liver Allografts and the Induction of Donor-Specific Unresponsiveness (Calne RY, ed) pp 222-253. Oxford University Press, Oxford
34. 34. Kamada N, Davies HS, Wight D, Culank L, Roser B (1983) Liver transplantation in the rat. Biochemical and histological evidence of complete tolerance induction in non-rejector strains. Transplantation 35:304-311
35. 35. Thomson AW, Lu L, Murase N, Demetris AJ, Rao AS, Starzl TE (1995) Microchimerism, dendritic cell progenitors and transplantation tolerance. Stem Cells (Dayt) 13:622-639
36. 36. Moskophidis D, Lechner F, Pircher H, Zinkernagel RM (1993) Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells (published erratum appears in Nature 1993 Jul 15;364(6434):262) (see comments). Nature 362:758-761
37. 37. Faustman DL, Steinman RM, Gebel HM, Hauptfeld V, Davie JM, Lacy PE (1984) Prevention of rejection of murine islet allografts by pretreatment with anti-dendritic cell antibody. Proc Natl Acad Sci USA 81:3864-3868
38. 38. Jacobs BB, Thuning CA, Sacksteder MR, Warren J (1979) Extended skin allograft survival in mice during prolonged exposure to hyperbaric oxygen. Transplantation 28:70-72.
39. 39. Welsh KI, Batchelor JR, Maynard A, Burgos H (1979) Failure of long surviving, passively enhanced kidney allografts to provoke T-dependent alloimmunity. II. Retransplantation of (AS × AUG)F1 kidneys from AS primary recipients into (AS × WF)F1 secondary hosts. J Exp Med 150:465-470
40. 40. Newstead CG, Johnston PA, Will EJ, Davison AM (1998) The case for withdrawal of cyclosporin after renal transplantation. Nephrol Dial Transplant 13:28-31
41. 41. Schreiber SL, Crabtree GR (1992) The mechanism of action of cyclosporin A and FK506. Immunol Today 13:136-142
42. 42. Lenschow DJ, Zeng Y, Thistlethwaite JR, Montag A, Brady W, Gibson MG, Linsley PS, Bluestone JA (1992) Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA-41g. Science 257:789-792
43. 43. Kirk AD, Harlan DM, Armstrong NN, Davis TA, Dong Y, Gray GS, Hong X, Thomas D, Fechner JH Jr, Knechtle SJ (1997) CTLA4-1g and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci USA 94:8789-8794
44. 44. Arnold B, Hammerling GJ (1991) MHC class-I transgenic mice. Annu Rev Immunol 9:297-322
45. 45. Heath WR, Kurts C, Miller JF, Carbone FR (1998) Cross-tolerance: a pathway for inducing tolerance to peripheral tissue antigens. J Exp Med 187:1549-1553
46. 46. Ohashi PS, Oehen S, Buerki K, Pircher H, Ohashi CT, Odermatt B, Malissen B, Zinkernagel RM, Hengartner H (1991) Ablation of 'tolerance' and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65:305-317
47. 47. Oldstone MB, Nerenberg M, Southern P, Price J, Lewicki H (1991) Virus infection triggers insulindependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 65:319-331
48. 48. Zinkernagel RM, Pircher HP, Ohashi P, Oehen S, Odermatt B, Mak T, Arnheiter H, Burki K, Hengartner H (1991) T and B cell tolerance and responses to viral antigens in transgenic mice: implications for the pathogenesis of autoimmune versus immunopathological disease. Immunol Rev 122:133-171
49. 49. Thomas L (1959) Cellular and humoral aspects of the hypersensitivity states, in Discussion to P.B. Medawar's paper (Lawerence HS, ed). Hoeber, New York
50. 50. Coley WB (1898) The treatment of inoperable sarcoma with the mixed toxins of erysipelas and bacillus prodigiosus. J Am Med Assoc Aug 20:389-395
51. 51. Ashley DM, Faiola B, Nair S, Hale LP, Bigner DD, Gilboa E (1997) Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors. J Exp Med 186:1177-1182
52. 52. Dranoff G, Jaffee E, Lazenby A, Golumbek P, Levitsky H, Brose K, Jackson V, Hamada H, Pardoll D, Mulligan RC (1993) Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 90:3539-3543
53. 53. Pan ZK, Ikonomidis G, Lazenby A, Pardoll D, Paterson Y (1995) A recombinant Listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour cell challenge and causes regression of established tumours. Nat Med 1:471-477
54. 54. Restifo NP (1996) The new vaccines: building viruses that elicit antitumor immunity. Curr Opin Immunol 8:658-663
55. 55. Fernandez N, Duffour MT, Perricaudet M, Lotze MT, Tursz T, Zitvogel L (1998) Active specific T-cell-based immunotherapy for cancer: nucleic acids, peptides, whole native proteins, recombinant viruses, with dendritic cell adjuvants or whole tumor cell-based vaccines. Principles and future prospects. Cytokines Cell Mol Ther 4:53-65
56. 56. Erti HC, Xiang Z (1996) Novel vaccine approaches. J Immunol 156:3579-3582
57. 57. Rosenberg SA, Yannelli JR, Yang JC, Topalian SL, Schwartzentruber DJ, Weber JS, Parkinson DR, Seipp CA, Einhorn JH, White DE (1994) Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2 (see comments). J Natl Cancer Inst 86:1159-1166
58. 58. Boismenu R, Hobbs MV, Boullier S, Havran WL (1996) Molecular and cellular biology of dendritic epidermal T cells. Semin Immunol 8:323-331
59. 59. Groh V, Steinle A, Bauer S, Spies T (1998) Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Science 279:1737-1740
60. 60. Bendelac A, Rivera MN, Park SH, Roark JH (1997) Mouse CD1-specific NK1 T cells: development, specificity and function. Annu Rev Immunol 15:535-562
61. 61. Morita CT, Tanaka Y, Bloom BR, Brenner MB (1996) Direct presentation of non-peptide phenyl pyrophosphate antigens to human gamma delta T cells. Res Immunol 147:347-353
62. 62. Constant P, Davodeau F, Peyrat MA, Poquet Y, Puzo G, Bonneville M, Fournie JJ (1994) Stimulation of human gamma delta T cells by nonpeptidic mycobacterial ligands. Science 264:267-270.
63. 63. Miller SD, Vanderlugt CL, Begolka WS, Pao W, Yauch RL, Neville KL, Katz-Levy Y, Carrizosa A, Kim BS (1997) Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading (see comments). Nat Med 3:1133-1136
64. 64. Forbes GM, Glaser ME, Cullen DJ, Warren JR, Christiansen KJ, Marshall BJ, Collins BJ (1994) Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-up (see comments). Lancet 343:258-260
65. 65. Cobbold SP, Qin S, Leong LY, Martin G, Waldmann H (1992) Reprogramming the immune system for peripheral tolerance with CD4 and CD8 monoclonal antibodies. Immunol Rev 129:165-201
66. 66. Sercarz EE, Lehmann PV, Ametani A, Benichou G, Miller A, Moudgil K (1993) Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol 11:729-766
67. 67. Todd J (1196) Textbook of pediatrics, in Rheumatic Fever (Nelson W, Behrman RE, Kliegman RM, Arvin AM, eds) pp 774-759. W.B. Saunders, Philadelphia
68. 68. Boyse EA, Carswell EA, Scheid MP, Old LJ (1973) Tolerance of Sk-incompatible skin grafts. Nature 244;441-442
69. 69. Vidovic D, Matzinger P (1988) Unresponsiveness to a foreign antigen can be caused by self-tolerance. Nature 336:222-225
70. 70. Horvitz HR, Shaham S, Hengartner MO (1994) The genetics of programmed cell death in the nematode Caenorhabditis elegans. Cold Spring Harb Symp Quant Biol 59:377-385
71. 71. Vyse TJ, Kotzin BL (1998) Genetic susceptibility to systemic lupus erythematosus. Annu Rev Immunol 16:261-292
72. 72. Gabrielsen AE (1974) Lupus erythematosus: a disease of D.N.A. discard? Lancet 2:1116-1118
73. 73. Frost PG, Lachmann PJ (1968) The relationship of desoxyribonuclease inhibitor levels in human sera to the occurrence of antinuclear antibodies. Clin Exp Immunol 3:447-455
74. 74. Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR (1998) Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 41:1241-1250
75. 75. Rosen A, Casciola-Rosen L (1998) Autoantigens as substrates for apototic proteases: implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ (in press)
76. 76. Rosen A, Casciola-Rosen L, Wigley F (1997) Role of metal-catalyzed oxidation reactions in the early pathogenesis of scleroderma. Curr Opin Rheumatol 9:538-543:
77. 77. Casciola-Rosen L, Wigley F, Rosen A (1997) Scleroderma autoantigens are uniquely fragmented by metal-catalyzed oxidation reactions: implications for pathogenesis. J Exp Med 185:71-79
78. 78. Streilein JW, Ksander BR, Taylor AW (1997) Immune deviation in relation to ocular immune privilege. J Immunol 1997 Apr 15. 158:3557-3560:
79. 79. Nilsen EM, Lundin KE, Krajci P, Scott H, Sollid LM Brandtzaeg P (1995) Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma. Gut 37:766-776
80. 80. Katz JD, Benoist C, Mathis D (1995) T helper cell subsets in insulin-dependent diabetes. Science 268:1185-1188
81. 81. Chen Y, Inobe J, Kuchroo VK, Baron JL, Janeway CA Jr, Weiner HL (1996) Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Proc Natl Acad Sci USA 93:388-391
82. 82. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL (1997) Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994 Aug 26. 265:1237-1240
83. + T cells through IL-12 produced by Listeria-induced macrophages (see comments). Science 260:547-549
84. 84. Forsthuber T, Yip HC, Lehmann PV (1996) Induction of TH1 and TH2 immunity in neonatal mice (see comments). Science 271:1728-1730
85. 85. Kojima S, Ovary Z (1976) Carrier effect by Nippostrongylus brasiliensis infection on rat antihapten IgE antibody response. Int Arch Allergy Appl Immunol 50:81-86:
86. 86. Flajnik MF, Canel C, Kramer J, Kasahara M (1991) Which came first, MHC class I or class II? Immunogenetics 33:295-300